ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

HEMO Hemogenyx Pharmaceuticals Plc

1.352
-0.083 (-5.78%)
Last Updated: 08:15:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.083 -5.78% 1.352 1.42 1.598 1.352 1.352 1.35 64,639 08:15:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -6.69M -0.0050 -2.86 19.26M
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1.44p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 1.002p to 6.30p.

Hemogenyx Pharmaceuticals currently has 1,341,815,988 shares in issue. The market capitalisation of Hemogenyx Pharmaceuticals is £19.26 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -2.86.

Hemogenyx Pharmaceuticals Share Discussion Threads

Showing 13351 to 13373 of 13625 messages
Chat Pages: 545  544  543  542  541  540  539  538  537  536  535  534  Older
DateSubjectAuthorDiscuss
05/4/2024
10:53
U.S. Application No. 17/133,448

Title: METHOD OF ELIMINATING HEMATOPOIETIC STEM CELLS/HEMATOPOIETIC
PROGENITORS (HSC/HP) IN A PATIENT USING BI-SPECIFIC ANTIBODIES
Applicant: HEMOGENYX LLC
Inventor: Vladislav Sandler
Issued as U.S. Patent No. 11,945,866 on April 2, 2024.

ashleyjv
05/4/2024
10:22
End of year results due 28/29th
dreamtwister
05/4/2024
10:15
Any reason why ?
john henry
05/4/2024
08:38
i can for-see a Drug shortage leading to costs rising due to the USA V CHINA Biodefence

Should congress pass the Legislation & it becomes Mandatory then i trust Dr Sandler has a plan B.

" The Consumer is Not the Customer !

dreamtwister
05/4/2024
08:13
https://www.londonstockexchange.com/news-article/APH/full-year-trading-update/16307097
blackhorse23
05/4/2024
07:30
No it appears to be that ashleyjv is spot on as it is now April [and the last day of the current tax year with the new tax year starting on Monday]
apotheki
04/4/2024
12:31
the security issues !The Fda have lifted the clinical hold but i find misleading

as Wuxi are the providers of the Lentivirus ?

dreamtwister
02/4/2024
11:54
reading the pharma rags this morning it brings sadness to see,

Redx's plans mirror those of C4X Discovery, which is also exiting AIM dissatisfied

with its lack of access to growth capital. I knowledge that Hemogenyx are listed

on the Main Market & the option to downgrade to the Aim market which would give

Hemogenyx Flexibility to raise further Equity or eclipse Redx/C4x with taking

the science private before a Hostile t/o with the present sultry share price or

Visa-versa spin off one of the other scientific platforms ! in the event of

Privatization Shareholder will receive a dividend should some financial Muscle

shows interest ?

dreamtwister
28/3/2024
15:13
Tax Year for Private Investors?
Hemo's was in December and hopefully the results are due to be next Month (April)

ashleyjv
28/3/2024
15:05
End of the trading month and quarter today - then just 4 trading days to the end of this tax year next week.

Reckon that ahead of the new tax year that next week could be better for small caps including of course Hemogenyx Pharmaceuticals

apotheki
28/3/2024
10:01
Tannedgirl…it’s doing well today yes.
albert35911
28/3/2024
10:00
Tannedgirl…230;if your brain exploded it wouldn’t mess up your hair.
albert35911
27/3/2024
21:59
24hr manufacturing ! yet to be tested in humans but proven in mouse models.



The on going bio-security.






Made in china ! Sounds plausible as they IPO the Data.

dreamtwister
27/3/2024
14:13
Not many suckers buying today,they must be getting wise.
albert35911
26/3/2024
13:44
Will Hemo spend Easter at 1.80p +
steveberyl
26/3/2024
11:33
so potentially as early as some time next week
apotheki
26/3/2024
11:31
And perhaps just perhaps news* after Easter

* The Company intends to progress HEMO-CAR-T to phase 1 clinical trials commencing shortly

apotheki
26/3/2024
11:03
Looks like placing shares have been digested
tsmith2
25/3/2024
15:11
Of course dear
albert35911
25/3/2024
08:30
Agreed that potentially this will become a TAKE OVER target for one of the American big boys!
apotheki
24/3/2024
11:40
Hope you are right CURMUDGEON, i have shares in both
steveberyl
24/3/2024
11:14
By this reasoning all humans need food so we should all buy every last penny we can in Sainsbury's or Waitrose. Utterly ridiculous statement.
trying2trade
24/3/2024
11:03
Reading the Cancer Statistics today in all the Papers, something needs to be done and quickly to stem the flow. It is affecting all walks of life, young & Old.

Hemo are certainly in the right place at the right time at a tad under 2p a pop.


I am certain to be joined by many others when buying as many as I can afford on Monday and every Day next week. Monarchy are virtually screaming, "BUY HEMO"

steveberyl
Chat Pages: 545  544  543  542  541  540  539  538  537  536  535  534  Older

Your Recent History

Delayed Upgrade Clock